few years. Private practitioners will be
able to make up the cost of the device
within a few months based on procedure
charges.
VAPCare-Tackling the Ventilator
Associated Pneumonia or VAP
About 200,000 deaths are attributed
to Ventilator Associated Pneumonia
(VAP). This also leads to 3.5 million ICU
days being lost and losses amounting to
$500,000. This product has an Indian
market opportunity of $300 million and
a global market opportunity of $3 billion.
The team has developed the sensor-
based, intelligent, closed-loop secretion
management system for ventilated
ICU patients to reduce the risk factors
BIOVOICENEWS.COM
29